The first international Pharmaceutical Compliance Congress and Best Practices Forum was held in Brussels in June 2007 to bring together company compliance professionals, regulators, lawyers, and consultants working in this interesting and expanding field. The purpose was to hold a truly global conference, addressing the key issues of the day. The first international conference agenda was mainly developed by company compliance professionals around topics that they wanted to know more about, which is one of the great strengths of these conferences and continues to be one of their key features.
In addition to Brussels, other international conferences have been held in Paris (2008), Rome (2009), Berlin (2010), Istanbul (2011) and Budapest (2012). Over the years the international conference agendas have developed to focus particular streams on the European Union (EU), Central and Eastern Europe (CEE ), and Middle East and Africa (MEA ), in addition to plenary sessions on global topics. The 2013 conference continues this trend.
The Seventh International Pharmaceutical Compliance Congress and Best Practices Forum focuses on ethics, anti-bribery, transparency requirements and industry body code updates. In addition to the major topics, the whole conference agenda promises to deliver informative and useful discussions on the key topics that may be causing company compliance officers varied levels of concern. The speaker line-up for this conference is very impressive, as usual. Whether the discussions are led by those working in life science companies, industry bodies, regulators, or consultancy/solutions companies, the information imparted at these conferences is always of the highest quality. These conferences are also a great opportunity to network with fellow compliance professionals and build relationships that often last for many years of mutual support and assistance.
In 2013 the new International Society of Healthcare Ethics and Compliance Professionals (ethics) has become the Congress sponsor and the Pharmaceutical Compliance Forum (PCF) has become the Congress co-sponsor.